Pharm Exam 2--opioids, anticonvulsants, NSAID, DMARD Flashcards
**Morphine
STRONG AGONIST
- binds to and stimulates ALL opiate receptors
- -closes Ca++ channels on presynaptic (all)
- –↓ ACh, NE, 5HT, *glutamate, *substance P
- -Mu also open K+ on postsynaptic- hyperpolarize
- -release HISTAMINE (orthostatic hypoTN)
- administered in all routes
- high first pass metabolism in liver
- -3-glucuronide (50%): more potent analgesia > morphine
- -6-glucuronide (5-15%): hyperalgesia, excitement, myoclonus
- excreted primarily in urine as 3-glucuronide (renal problems metabolite accumulates?)
EFFECTS
-Analgesia: sensory & affective; (tolerance)-mu, kappa
-Sedation/mental clouding (tolerance)-mu
-Euphoria or dysphoria (kappa & delta) (tolerance)-mu
-Nausea: direct stim of CTZ (tolerance)
(Mu → side-effects)
- Anti-tussive: lower doses
- Respiratory depression: ↑ PaCO2
- -good: pulm edema; bad: COPD, asthma, cor pulmonale
- MIOSIS (no tolerance)
- ↑ intracranial pressure: due to ↑ CO2 (vasodilate, ↑ flow)
- ↓ body temp
- Truncal rigidity
- Cardiovascular: bradycardia (not direct), orthostatic hypoTN
- GI: CONSTIPATION (no tolerance)
- GU: retention
- Uterus: relax
Hydromorphone (Dilaudid)
STRONG AGONIST
- morphine derivative
- more potent and as effective as morphine
- *-used w/ Renal dysfunction–metabolites don’t accumulate
- –like they will w/ Meperidine
- *-less itching than morphine
- slightly shorter DOA than morphine
Heroin
STRONG AGONIST
- schedule I drug
- easily passes BBB and is metabolized → morphine
- 10x more potent than morphine
- high abuse potential
Methadone (Dolophine)
STRONG AGONIST
- *longer DoA than morphine
- potent mu agonist
- BLOCKS NMDA receptors– ↓ tolerance
- ↓ reuptake of Monoamines
- used in HARD TO TREAT pain (neuropathic, cancer)
- tolerance & dependence occur more slowly
- helps ↓ withdrawl symptoms in heroin addicts
- more mild but longer withdrawl
- absorbed more slowly → doesn’t produce high
Meperidine (Demerol)
STRONG AGONIST
- short DoA (not for long term use)
- antimuscarinic → tachycardia, dilates pupils
- blocks reuptake of Serotonin (TCA or SSRI)
- use in healthy pts and/or pts that have problems w/ other opiate agonists (NOT long term)
- -too short DoA
- -**metabolites (normeperidine) accumulate
- -anxiety & **SEIZURES (w/ Renal failure cause seizures)
- -OD can cause excitement and convulsion
- euphoria → significant addiction potential
- **doesnt suppres COUGH
- **doesnt cause MIOSIS
- do not use w/ MAOI (phenelzine, selegiline, linezolid)
- -can cause serotonin syndrome
-reduces shivering (and other emergence symptoms?)
Fentanyl (Sublimaze) #
-preffered over morphine in anesthesia-
STRONG AGONIST
- highly LIPID soluble
- 100x more potent than morphine
- shorter DoA and 1/2life than morphine or meperidine (abuse potential)
- used to aid induction & maintenance of GA
- supplement regional & spinal analgesia
- -attenuate hemodynamic responses & maintain cardiac stability
- -administered in various forms (transdermal, lozenges)
- extensively metabolized by CYP3A4- significant interaction w/ inhibitors or inducers
- tolerance and dependance less common
-truncal rigidity → NM blocker b/c hard to breat
Alfentanil / Sufentanil / Remifentabuk
STRONG AGONIST
- primarily used in anesthesia
- faster onset & shorter DoA than fentanyl
- IV or epidural
- undergoes liver biotransformation via CYP3A4
- -interactions w/ agents that inhibit CYP3A4
-truncal rigidity
Hydrocodone (Codan)
+ acetaminophen = Vicodin
Moderate-to-Strong AGONIST
- synthetic codeine derivative
- undergoes complex hepatic metabolism:
- -O & N demethylation
- -6-keto reduction
- –6-α and 6-β hydroxy active metabolites
- *–some is converted to HYDROMORPHONE (CYP2D6)
- inhibitors of CYP2D6 (quinidine & SSRI) reduce analgesia
-does have a direct action on Mu rececptors
Oxycodone (OxyContin)
+ acetaminophen = Percoset
Moderate-to-Strong AGONIST
- similar to hydrocodone and morphine
- treats cancer pain, posoperative, postextractional, and post partum pain
- *Restless Leg and Tourettes syndromes
- oral administration
- distributed to skeletal muscle, liver, intestinal tract, lungs, spleen, CNS
- metabolized by liver excreted in urine
- has direct action but requires metabolism via CYP2D6
- -oxymorphone (SSRI will ↓)
Oxymorphone (Opana)
Moderate-to-Strong AGONIST
- IF patient is on SSRI
- active metabolite of oxycodone
- effects similar to morphine or oxycodone
- very potent
Codeine
MODERATE agonist & **Antitussive
- at higher doses- analgesic and addictive properties
- *-does not bind to Mu receptor-
- -will not compete w/ strong agonists
- partially metabolized to morphine by CYP2D6 (analgesic)
- use caution w/ small children (<2 yrs)
- frequently combined w/ aspirin or acetaminophen
-OD can cause excitement and convulsion
Tramadol (Ultram)
MODERATE agonist/ Multiple Actions
- weak Mu agonist
- inhibits reuptake of NE and 5HT
- not completely inhibited by Naloxone
- good analgeisa (codeine) w/ mild opioid like SE
- combo w/ *antidepressants → *SEIZURES
- should not be combined w/ TCA. SSRI, MAOI → serotonin syndrome
Buprenorphine (Buprenex)
MIXED agonist-antagonist
- partial agonist at Mu & possibly Kappa receptors
- less analgesia than morphine
- **much less abuse potential than morphine
- **Reduces drug craving in heroin addicts
- IV, **sublingual, nasal
- formulated w/ Naloxone which cannot be absorbed sublingually and prevents it from IV use
- acts as antagonist if combined w/ strong agonist
Pentazocine (Talwin)
MIXED agonist-antagonist
-used for MODERATE pain
- agonist at kappa** (analgesia)
- *partial at mu
- less sedation, respiratory depression, and GI effects
- dysphoria*, CNS stim, hallucinations
- can precipitate withdrawl syndrome
-combination w/ strong agonists is CI
Naloxone (Narcan)
PURE ANTAGONIST
- DOC for opioid overdose
- high 1st pass– usually given IV**
- reverse respiratory depressant effects of opioids
- short DoA**
- can precipitate withdrawls in addicts
Naltrexone (ReVia)
ANTAGONIST
- orally effective
- long acting (24hrs)
- prevents recovering addicts from getting high
- must be detoxified (withdrawl) before therapy
- ↓ craving in alcoholics
- risk of HEPATOTOXICITY
Dextromethorphan
ANTITUSSIVE
- blocks NMDA receptros (may ↑ morphine analgesic)
- block neuronal uptake of 5HT
- -combo w/ MAOI can cause serotonin syndrome
- no analgesic effect
- less constipation than codeine
-excess pure detromethorphan in powder can cause death, brain damage, seizures, loss of consciousness, irregular heart beat
Diphenoxylate plus atropine
ANTIDIARRHEAL
Loperamine (Imodium)
ANTIDIARRHEAL
-Tapentadol
MODERATE AGONIST/ Mutli Actions
- similar to tramadol
- mu receptor agonist
- inhibits NE re-uptake (chronic & neuropathic pain)
- stimulate α2
- nausea, vomiting, sedation
–Nalmefene
ANTAGONIST
- used for treatment of opioid OD
- similar to naloxone but longer DoA
- chronic treatment of alcoholism
- LESS liver toxicity than Naltrexone
Esters
- shorter DoA
- ↑ degree of systemic toxicity
- -PABA inhibits action of sulfonamides
- rapidly metabolized by butyrylcholinesterase in plasma
Connects lipophilic group to ionizable group
-weak bases (pKa 8-9)
(Procaine, Tetracaine, Benzocaine, Cocaine)
Amide
- longer DoA
- ↓ degree of systemic toxicity
- metabolized in liver (CYP450)
Connects lipophilic group to ionizable group
-weak bases (pKa 8-9)
-Lidocaine*, Prilocaine, Bupivacaine, Mepivacaine, Ropivacaine, Etidocaine, Articaine
Benzocaine
ESTER
- TOPICAL ONLY: treat puritis in OTC, sunburn, minor burns
- *very lipophilic
- **pKa ~3.5- non-ionized at physiological pH
-potential link to met-Hb
Bupivicaine (Marcaine)
AMIDE
- long DoA
- **sensory before motor (more sensory than motor)
- infiltration, spinal anesthesia, ***epidural
- post-op pain control
- **greater cardiotoxicity
- -high affinity to resting cardiac Na channels
- -reverse w/ lipids
- -do NOT use for IV regional anesthesia
Etidocaine
AMIDE
- long DoA
- rarely used for infiltrative, peripheral, or epidural blocks
- **motor before (or w/o) sensory block
- may cause inverse differential block
Prilocaine
AMIDE
- intermediate DoA
- **Highest rate of clearance (careful w/ pts w/ liver damage)
- metabolite may produce met-Hb
- limited to dentistry due to met-Hb
- do NOT use in pts w/
- -cardiac or respiratory disease
- -idiopathic/congenital met-Hb-emia
- reverse w/ methylene blue
**Procaine
ESTER
- used in infiltration anesthesia & *diagnostic blocks
- short DoA
- potency of others are RELATIVE to Procaine
- PABA metabolic product → ↓ action sulfonamide
- minimal systemic toxicity
- no local irritation
- available w/ or w/o epi (2x DoA)
Tetracaine
ESTER
- *spinal anesthesia w/ dextrose (heavier than CSF)
- used for ophthalmological
- long DoA & slow onset of action
- 16x more potent/toxic than procaine
**Lidocaine (Xylocaine)
AMIDE
- infiltration & epidural anesthesia
- intermediate DoA; potency of 4
- rapid onset, minimal local irritation
- some topical activity
- **Transient neurological symptoms (transient pain, dysesthesia)
- -if used as spinal anesthesia (NOT DOC for spinal)
Cocaine
ESTER
- topical anesthesia of mucous membranes around URT
- short acting
- topical only
- ↑ catecholamine in CNS and periphery
- -vasoconstriction
NARCOTIC:
- ↓ repuptake of DA (and NE)
- energy burst, euphoria
- stimulates SYMPATHETIC
- -↑ HR, BP → cerebral hemorrhage
- -mydriasis
- -↓ appetite
-hyperthermia, seizures
Ropivicaine
AMIDE
- high volume peripheral blocks & epidural
- S-enatiomer of bupivicaine
- **less cardiac toxicity
- **less lipid soluble & cleared more rapidly
- -adverse effects less likely
- PHK similar to bupivicaine
- minor vasoconstricting
Mepivacaine
AMIDE
- peripheral nerve blocks
- NOT used in labor → toxic to neonate
- intermediate DoA
- potency 2
Articaine
AMIDE
- has additional ester group- esterases metabolize
- -↓ half-life & systemic toxicity
- widely used in dentistry
- -large therapeutic window & low potential systemic toxic
- -can inject more later
- may devole persistent paresthesias
Dibucane
AMIDE
- inhibits butyryl-AChase
- Dibucaine numer shows activity of butyryl-AChease
- differentiate b/w substitution mutations of butyryl-AChease
- inhibits wild type (normal) MORE than mutated type
nicotine
(use and mechanism)
-Activates nicotinic receptors in CNS & periphery
PERIPHERY
–↑ Epi release
–↑ HR, BP
–↑ tone & activity of GI
CNS
–**↑ 5HT & DOPAMINE release (↑ DA → endogenous opioid)
–effects memory and learning (nicotinic receptors)
-induces CYP450
- psychological & physical dependence; withdrawal
- -Buproprion ↓ craving (receptors up-regulated)
marijuana
(effects and drawbacks w. chronic use, medical effects)
- targets presynaptic cannabinoid receptor (CB1) to alter NTM release
- inhibits ACh & glutamate release
- -impairs memory & cognitive function of hippocampus
HARMFUL EFFECTS:
- amotivational syndrome
- ↓ testoserone
- depression, paranoia, panic
MEDICAL EFFECTS
- anti-emetic
- analgesia
MDMA
(mxn, effects, toxicity)
- Blocks 5HT transporter (SERT)
- ↑ 5HT release
- ↑ postsnyaptic 5HT receptors (↑ 5HT all over brain)
-causes feelings of peace, empathy, acceptance
- neruotoxic due to SERT inhib
- can cause confusion, depression, anxiety, insomnia etc
- death due to dehydration, hyperthermia, heart, kidney failure